Human collagen II peptide 256-271 preferentially binds to HLA-DR molecules associated with susceptibility to rheumatoid arthritis

Immunogenetics

Volumn 49, Issue 1, 1999, Pages 36-44

  Diab, Bader Yassine ^a   Lambert, Nathalie C ^a   L'Faqihi, Fatima Ezzahra ^a   Loubet Lescoulié, Patrick ^a   De Préval, Claude ^a   Coppin, Hélène ^a  

^a CHU PURPAN   (France)

Author keywords

Binding; Collagen II; Peptide; Rheumatoid arthritis

Indexed keywords

COLLAGEN TYPE 2; HLA DR ANTIGEN;

ARTICLE; DISEASE PREDISPOSITION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; BINDING SITES; BINDING, COMPETITIVE; COLLAGEN; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032959873     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050461     Document Type: Article

References (54)

1. Amagai M, Klaus-Kovtun V, Stanley JR (1991) Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67:869-877
2. Banerjee S, Luthra HS, Moore SB, O'Fallon WM (1998) Serum IgG anti-native type II collagen antibodies in rheumatoid arthritis: association with HLA DR4 and lack of clinical correlation. Clin Exp Rheumatol 6:373-380
3. Brand DD, Myers LK, Terato K, Whittington KB, Stuart JM, Kang AM, Rosloniec EF (1994) Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine alpha 1(II)-CB11 in H-2q mice. J Immunol 152:3088-3097
4. Brunsberg U, Gustafsson K, Jansson L, Michaëlsson E, Ährlund-Ritcher L, Pettersson S, Mattsson R, Holmdahl R (1994) Expression of z transgenic class II ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol 24:1698-1702
5. Busch R, Rothbard J.B (1990) Detection of peptide-MHC class II complexes on the surface of intact cells. J Immunol Methods 134:1-22
6. Calman AF, Peterlin BM (1987) Mutant human B cell lines deficient in class II major histocompatibility complex transcription. J Immunol 139:2489-2495
7. Choi EK, Gatenby PA, McGill NW, Bateman JF, Cole WG, York JR (1988) Autoantibodies to type II collagen: occurrence in rheumatoid arthritis, other arthritides autoimmune connective tissue diseases and chronic inflammatory syndromes. Ann Rheum Dis 47:313-322
8. Clague RB, Firth SA, Holt PJL, Skingle J, Greenbury CL, Webley M (1983) Serum antibodies to type II collagen in rheumatoid arthritis: comparison of 6 immunological methods and clinical features. Ann Rheum Dis 42:537-544
9. Coppin HL, Carmichael P, Lombardi G, L'Faqihi F-E, Salter R, Parham P, Lechler RI, De Préval C (1993) Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition. Eur J Immunol 23:343-349
10. Deighton CM, Kelly PJ, Walker DJ (1993) Linkage of rheumatoid arthritis with HLA. Ann Rheum Dis 52:638-642
11. Demotz S, Barbey C, Corradin G, Amoroso A, Lanzavecchia A (1993) The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86. Eur J Immunol 23:425-432
12. Dessen A, Lawrence CM, Cupo S, Zaller DM, Wiley DC (1997) X-ray crystal structure of HLA-DR4 (DRα*0101 DRβ1*0401) complexed with a peptide from human collagen II. Immunity 7:473-781
13. Elkayam O, Zinger H, Zisman E, Segal R, Taron M, Brautbar C, Moses E (1991) Regulatory T cell activity specific to human type II and III collagens in rheumatoid arthritis. J Rheumatol 18:516-521
14. Fu XT, Bono CP, Woulfe SL, Swearingen C, Summers NL, Sinigaglia F, Sette A, Schwartz BD, Karr RW (1995) Pocket 4 of the HLA-DR (alphabeta 1*0401) molecule is a major determinant of T cells recognition of peptide. J Exp Med 181:915-926
15. Fugger L, Rothbard JB, Sonderstrup-McDevitt G (1996) Specificity of an HLA-DRβ1*0401-restricted T cell response to type II collagen. Eur J Immunol 26:928-933
16. Gao X, Brautbar C, Gazit E (1991) A variant of HLA-DR4 determines susceptibility to rheumatoid arthritis in a subset of Israeli Jews. Arthritis Rheum 34:547-551
17. Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205-1213
18. Griffiths MM, Dewitt CW (1981) Immunogenetic control of experimental collagen-induced arthritis in rats II ECIA susceptibility and immune response to type II collagen (CALF) are linked to RT1. J Immunogenet 8:463-470
19. Hammer J, Gallazzi F, Bono E, Karr RW, Guenot J, Valsasnini P, Nagy ZA, Sinigaglia F (1995) Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med 181:1847-1855
20. Holmdahl R, Andersson M, Goldschmidt TJ, Gustafsson K, Jansson L, Mo J A (1990) Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev 118:193-232
21. Holmdahl R, Vingsbo C, Mo JA, Michaëlson E, Malmström V, Jansson L, Brunsberg U (1995) Chronicity of tissue-specific experimental autoimmune disease: a role for B cells? Immunol Rev 144:109-135
22. Jurcevic S, Praud C, Coppin H, Bertrand A, Ricard S, Thomsen M, Lakhdar-Ghazal F, De Préval C (1996) Role of polymorphic residues of human leucocyte antigen-DR molecules on the binding of human immunodeficiency virus peptides. Immunology 87:414-420
23. Khare SD, Krco CJ, Griffiths MM, Luthra HS, David CS (1995) Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. J Immunol 155:3653-3659
24. Kirshmann DA, Duffin KL, Smith CE, Welply JK, Howard SC, Schwartz BD, Woulfe SL (1995) Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles. J Immunol 155:5655-5662
25. p molecules. Eur J Immunol 28:755-767
26. Krco CJ, Pawelski J, Harders J, McCormick D, Griffiths M, Luthra HS, David CS (1996) Characterization of the antigenic structure of human type II collagen J Immunol 156:2761-2768
27. Londei M, Savill CM, Averhoef A, Brennan F, Leech ZA, Duance V, Maini RN, Feldmann M (1989) Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci USA 86:636-640
28. Marshall KW, Liu AF, Canales J, Perahia B, Jorgensen B, Gantzos RD, Aguilar B, Devaux B, Rothbard JB (1994) Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. J Immunol 152:4946-4957
29. Matsushita S, Takahashi K, Motoki M, Komoriya K, Ikagawa S, Nishimura Y (1994) Allele specificity of structural requirement for peptides bound to HLA-DRβ1*0405 and -DRβ1*0406 complexes: implication for the HLA associated susceptibility to methimazole-induced insulin autoimmune syndrome. J Exp Med 180:873-883
30. Michaëlsson E, Andersson M, Engström A, Holmdahl (1992) Identification of an immunodominant type-II collagen peptide recognized by T cells in H2q mice: self tolerance at the level of determinant selection. Eur J Immunol 22:1819-1825
31. McNicholl JM, Whitworth WC, Oftung F, Fu X, Shinnick T, Jensen PE, Simon M, Wohlhueter RM, Karr RW (1995) Structural requirements of peptide and MHC for DR(alpha beta 1*0401)-restricted T cell antigen recognition. J Immunol 155:1951-1963
32. Nanda NK, Arzoo KK, Geysen HM, Sette A, Sercarz EE (1995) Recognition of multiple peptide cores by a single T cell receptor. J Exp Med 182:531-539
33. Nepom GT, Ou D, Lybrand TP, DeWeese C, Ellen-Domeier M, Buckner JH, Mitchell LA, Tingle AJ (1996) Recognition of altered self major histocompatibility complex molecules modulated by specific peptide interactions. Eur J Immunol 26:949-952
34. Newton-Nash DK, Eckels D (1992) Effects of localized HLA class II beta chain polymorphism on binding of antigenic peptide and stimulation of T cells. Hum Immunol 33:213-223
35. Ohta B, Nishimura YK, Tanimoto K (1982) Association between HLA and Japanese patients with rheumatoid arthritis. Hum Immunol 5:123-132
36. Pande H, Baak SW, Riggs AD, Clark BR, Shively JE, Zaia JA (1984) Cloning and physical mapping of a gene fragment coding for a 64-kilodalton major late antigen of human cytomegalovirus. Proc Natl Acad Sci USA 81:4965-4969
37. Rammensee HG, Friede T, Stevanović S (1995) MHC ligands and peptide motifs: first listing. Immunogenetics 41:178-228
38. Rammensee HG (1995) Chemistry of peptides associated with MHC class I and class II molecules. Curr Opin Immunol 7:85-96
39. Roche PA, Cresswell P (1990) High-affinity binding of an influenza hemagglutinin derived peptide to purified HLA-DR. J Immunol 144:1849-1856
40. Rosloniec EF, Brand DD, Myers LK, Whittington KB, Gumanovskaya M, Zaller DM, Woods A, Altman DM, Stuart JM, Kang AH (1997) An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med 185:1113-1122
41. Rowley MG, Williamson DJ, Mackay IR (1987) Evidence for local synthesis of antibodies to denatured collagen in the synovium in rheumatoid arthritis. Arthritis Rheum 30:1420-1425
42. Sample J, Young L, Martin B, Chatman T, Kieff ED, Rickinson A (1990) Epstein-Barr virus types 1 and 2 differ in their EBNA-3 A EBNA-3B and EBNA-3 C genes. J Virol 64: 4084-4092
43. Sanchez B, Moreno I, Magarino R (1990) HLA-DRw10 confers the highest susceptibility to rheumatoid arthritis in a Spanish population. Tissue Antigens 36:174-176
44. Sette A, Sidney J, Oseroff C, del Guercio MF, Southwood S, Arrhenius T, Powell MF, Colon SM, Gaeta FCA, Grey HM (1993) HLA-DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J Immunol 151:3163-3170
45. Spire B, Sire J, Zachar V, Rey F, Klatzmann D, Galibert F, Hampe A, Chermann JC (1989) Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus. Gene 81:275-284
46. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215-221
47. Trentham DE, Dynesisu-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL (1993) Effects of oral administration of type II collagen on rheumatoid arthritis. Science. 261:1727-1730
48. Trentham DE, Kammer GM, McCune WJ, David RJ (1981) Autoimmunity to collagen: a shared feature of psoriatic and rheumatoid arthritis. Arthritis Rheum 24:1363-1369
49. Trentham DE, Townes A, Sand Kang AH (1977) Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 146: 857-868
50. Willkens RF, Nepom GT, Maks C, Nettles JW, Nepom BS (1991) Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians: further evidence for the "shared epitope" hypothesis. Arthritis Rheum 34:43-47
51. Wucherpfennig KW, Yu B, Bhol K, Monos DS, Argyris E, Karr RW, Ahmed AR (1995) Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci USA 92:11935-11939
52. Yoo TJ, Kim SY, Stuart JM, Floyd RA, Olson GA, Cremer MA, Kang AH (1988) Induction of arthritis in monkeys by immunization with type II collagen. J Exp Med 168:777-782
53. Zeliszewski D, Gaudebout P, Golvano JJ, Dorval I, Prévost A, Borras-Cuesta F, Sterkers G (1994) Molecular basis for degenerate T-cell recognition of one peptide in the context of several DR molecules. Hum Immunol 41:28-33
54. Zeliszewski D, Golvano JJ, Gaudebout P, Dorval I, Freidel C, Gebuhrer L, Betuel H, Borras-Guesta F, Sterkers G (1993) Implication of HLA-DR residues at positions 67, 71 and 86 in interaction between HLA-DR11 and peptide HA306-320. J Immunol 151:6237-6247